File:BCR-ABL-Mutationen.svg

From Wikimedia Commons, the free media repository
Jump to navigation Jump to search

Original file ‎(SVG file, nominally 481 × 831 pixels, file size: 459 KB)

Captions

Captions

Add a one-line explanation of what this file represents

Summary[edit]

Description
Deutsch: Empfindlichkeit verschiedener BCR-ABL-Mutationen gegenüber den Tyrosinkinase-Inhibitoren Imatinib, Nilotinib und Dasatinib.
English: Sensitivity of different BCR-ABL mutations against tyrosine kinase inhibitors imatinib, nilotinib and dasatinib.
Date
Source

compiled from data published by:

  • O'Hare T, Eide CA, Deininger MW: Bcr-Abl kinase domain mutations, drug resistance, and the road to a cure for chronic myeloid leukemia. Blood 2007 Oct 1;110(7):2242-9. PMID 17496200
  • Branford S, Melo JV, Hughes TP: Selecting optimal second-line tyrosine kinase inhibitor therapy for chronic myeloid leukemia patients after imatinib failure: does the BCR-ABL mutation status really matter? Blood. 2009 Dec 24;114(27):5426-35. PMID 19880502
  • O'Hare T, Eide CA, Deininger MWN: Bcr-Abl kinase domain mutations, drug resistance, and the road to a cure for chronic myeloid leukemia. Blood 2007;110(7):2242-2249. PMID 17496200
  • Redaelli S, Piazza R, Rostagno R, et al. Activity of bosutinib, dasatinib, and nilotinib against 18 imatinib-resistant BCR/ABL mutants. J Clin Oncol 2009;27(3):469-471. PMID 19075254
Author Furfur

Licensing[edit]

I, the copyright holder of this work, hereby publish it under the following licenses:
GNU head Permission is granted to copy, distribute and/or modify this document under the terms of the GNU Free Documentation License, Version 1.2 or any later version published by the Free Software Foundation; with no Invariant Sections, no Front-Cover Texts, and no Back-Cover Texts. A copy of the license is included in the section entitled GNU Free Documentation License.
w:en:Creative Commons
attribution share alike
This file is licensed under the Creative Commons Attribution-Share Alike 3.0 Unported, 2.5 Generic, 2.0 Generic and 1.0 Generic license.
You are free:
  • to share – to copy, distribute and transmit the work
  • to remix – to adapt the work
Under the following conditions:
  • attribution – You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
  • share alike – If you remix, transform, or build upon the material, you must distribute your contributions under the same or compatible license as the original.
You may select the license of your choice.

File history

Click on a date/time to view the file as it appeared at that time.

Date/TimeThumbnailDimensionsUserComment
current11:29, 29 May 2011Thumbnail for version as of 11:29, 29 May 2011481 × 831 (459 KB)Furfur (talk | contribs)...Details
13:11, 28 May 2011Thumbnail for version as of 13:11, 28 May 2011481 × 831 (458 KB)Furfur (talk | contribs)scale x2
13:07, 28 May 2011Thumbnail for version as of 13:07, 28 May 2011277 × 436 (459 KB)Furfur (talk | contribs){{Information |Description ={{de|1=Empfindlichkeit verschiedener BCR-ABL-Mutationen gegenüber den Tyrosinkinase-Inhibitoren Imatinib, Nilotinib und Dastinib.}} {{en|1=Sensitivity of different BCR-ABL mutations against tyrosine kinase inhibitors imatin

You cannot overwrite this file.

There are no pages that use this file.

File usage on other wikis

The following other wikis use this file:

Retrieved from "https://commons.wikimedia.org/w/index.php?title=File:BCR-ABL-Mutationen.svg&oldid=810294257"